Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H14NO5P |
Molecular Weight | 259.1956 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOP(=O)(CC)OC1=CC=C(C=C1)[N+]([O-])=O
InChI
InChIKey=XXUJMEYKYHETBZ-UHFFFAOYSA-N
InChI=1S/C10H14NO5P/c1-3-15-17(14,4-2)16-10-7-5-9(6-8-10)11(12)13/h5-8H,3-4H2,1-2H3
DescriptionSources: http://dxline.ru/drugs/arminCurator's Comment: description was created based on several sources, including:
http://www.medicinform.net/spravka/b1/b1_82.htm
https://ru.wikipedia.org/wiki/%D0%90%D1%80%D0%BC%D0%B8%D0%BD
Sources: http://dxline.ru/drugs/armin
Curator's Comment: description was created based on several sources, including:
http://www.medicinform.net/spravka/b1/b1_82.htm
https://ru.wikipedia.org/wiki/%D0%90%D1%80%D0%BC%D0%B8%D0%BD
Armin is irreversible cholinesterase inhibitor. It acts considerably longer and stronger than reversible cholinesterase inhibitors. It is used for glaucoma treatment. Armin might be used in combination with other antiglaucoma drugs. Known adverse effects are: hypersalivation, sweating, dyspepsia, frequent urination, blurred vision, headache, dizziness, twitching of the tongue and skeletal muscles, nausea, vomiting.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: http://dxline.ru/drugs/armin
1-2 drops 2-3 times per daily
Route of Administration:
Topical
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Armine (chemical)
Created by
admin on Fri Dec 15 17:20:00 GMT 2023 , Edited by admin on Fri Dec 15 17:20:00 GMT 2023
|
PRIMARY | |||
|
D001138
Created by
admin on Fri Dec 15 17:20:00 GMT 2023 , Edited by admin on Fri Dec 15 17:20:00 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106820
Created by
admin on Fri Dec 15 17:20:00 GMT 2023 , Edited by admin on Fri Dec 15 17:20:00 GMT 2023
|
PRIMARY | |||
|
546-71-4
Created by
admin on Fri Dec 15 17:20:00 GMT 2023 , Edited by admin on Fri Dec 15 17:20:00 GMT 2023
|
PRIMARY | |||
|
H39MRI1X2O
Created by
admin on Fri Dec 15 17:20:00 GMT 2023 , Edited by admin on Fri Dec 15 17:20:00 GMT 2023
|
PRIMARY | |||
|
DTXSID5048843
Created by
admin on Fri Dec 15 17:20:00 GMT 2023 , Edited by admin on Fri Dec 15 17:20:00 GMT 2023
|
PRIMARY | |||
|
66067
Created by
admin on Fri Dec 15 17:20:00 GMT 2023 , Edited by admin on Fri Dec 15 17:20:00 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD